Health - Hepatitis latest news

Movetis NV, a European specialist pharmaceutical company, announced that M0002 is progressing to phase IIb following positive results of a phase IIa multiple-dosing trial for the treatment of ascites, the accumulation of fluid in the abdomen in patients with liver cirrhosis resulting from liver conditions such as hepatitis C, hepatitis B or alcoholism.

Children should be vaccinated against hepatitis to prevent the spread of medicine-resistant strains of the disease, according to a report published by The Association of The British Pharmaceutical Industry .

Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported additional interim results from its ongoing phase I/II clinical study of its ChronVac-C® therapeutic DNA vaccine, which is delivered using Inovio's electroporation-based DNA delivery system.

In general, I think diversity is a great thing. Diversity in culture, people and ideas is wonderful.

Ask his fellow musicians about Alejandro Escovedo, and you'll hear nothing but praise.